ISPE Appoints Tim Howard as Acting CEO and President

The International Society for Pharmaceutical Engineering (ISPE) has appointed...
The International Society for Pharmaceutical Engineering (ISPE) has appointed Tim Howard as the organization’s acting CEO and president. © ISPE

The International Society for Pharmaceutical Engineering (ISPE) has appointed Tim Howard as the organization’s acting CEO and president. John Bournas, the former CEO and president, stepped down from his position effective Jan. 8, 2020. Howard has taken a leave of absence from his current industry position and will lead the ISPE team under the direction of the ISPE Board until a permanent replacement will be found.

Before taking on the role as acting CEO and president of ISPE, Howard has held various senior roles at Commissioning Agents Inc. (CAI), most recently as vice president Human Resources. From 2011 to 2019, he was a member of the international board of directors of ISPE, serving as chair in 2018. Howard holds a B.S. degree in Mechanical Engineering from North Carolina State University.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.